Advertisement
Advertisement

XENE

XENE logo

Xenon Pharmaceuticals Inc

39.76
USD
+1.51
+3.95%
Jan 14, 15:58 UTC -5
Closed
...

Xenon Pharmaceuticals Inc Profile

About

Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is focused on the development of medicines through the application of its proprietary discovery platform, which it refer to as Extreme Genetics. Xenon is developing proprietary product candidates for the treatment of both orphan as well as more prevalent diseases. The company offers Glybera (R), a gene therapy for the treatment of lipoprotein lipase deficiency, an orphan disorder. Xenon Pharmaceuticals Inc. is headquartered in Burnaby, Canada.

Info & Links

CEO

Ian Mortimer

Headquarters

200 - 3650 GILMORE WAY
BURNABY, A1 V5G 4W8, CANADA

Industry

Pharmaceuticals Major

Sector

Health Technology

Website

www.xenon-pharma.com

Auditor

KPMG LLP

Share holders

82

Employees

259

Xenon Pharmaceuticals Inc Statistics

Valuation Measures

Market Capitalization2

3.03B

Enterprise Value

2.94B

Enterprise Value/EBITDA(ttm)

-11.65

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

3.65

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-24.69%

Return on Invested Capital(ttm)

-24.95%

Return on Assets(ttm)

-23.68%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-252.74M

Net Income Available to Common(ttm)

-213.39M

Diluted EPS(ttm)

-2.82

Share Statistics

Beta (5Y Monthly)

1.20

52-Week Change

5.30%

S&P 500 52-Week Change

22.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

76.24M

Dividend Yield

0.00%

Float4

72.03M

% Held by Insiders

5.52%

% Held by Institutions

95.45%

Balance Sheet

Total Cash(mrq)

654.01M

Total Cash Per Share(mrq)

8.58

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

22.21%

Quick Ratio(mrq)

22.21%

Book Value Per Share(mrq)

10.53

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.63

Free Cash Flow(ytd)

-129.30M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement